NOVAVAX INC — Director's Dealing 2021

Mar 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2021-03-15

Reporting Person: EVANS GARY C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-15	Common Stock	M	2000	$99.80	Acquired	18099	Direct
2021-03-15	Common Stock	M	4500	$46.00	Acquired	22599	Direct
2021-03-15	Common Stock	M	18000	$3.985	Acquired	40599	Direct
2021-03-15	Common Stock	S	9732	$210.00	Disposed	30867	Direct
2021-03-15	Common Stock	S	14768	$212.00	Disposed	16099	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-15	Stock Option (Right to Buy)	$99.80	M	2000	Disposed	2026-03-15	Common Stock (2000)	Direct
2021-03-15	Stock Option (Right to Buy)	$46.00	M	4500	Disposed	2028-12-13	Common Stock (4500)	Direct
2021-03-15	Stock Option (Right to Buy)	$3.985	M	18000	Disposed	2029-12-12	Common Stock (18000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	625	Indirect

Footnotes

F1: The reporting person indirectly beneficially owns 625 shares held by the Evans 1997 Trust.

F2: One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan") vested six (6) months from the March 15, 2016 grant date.

F3: One hundred percent (100%) of the shares subject to this option grant under the Plan vested one (1) year from the December 13, 2018 grant date.

F4: One hundred percent (100%) of the shares subject to this option grant under the Plan vested one (1) year from the December 12, 2019 grant date.